The Food and Drug Administration on Monday approved the first screening test for colon cancer that uses patients' DNA to help spot potentially deadly tumors and growths.
A Spanish missionary priest is the third Westerner with Ebola to be treated with an experimental drug that's never been tested in people and is said to be in very limited supply.
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UC San Francisco (UCSF).
In An Account of the Foxglove and Some of its Medical Uses, published in 1785, Sir William Withering cautioned readers that extracts from the plant foxglove, also called digitalis, was not a perfect drug. "Time will fix the ...
(HealthDay)—As the number of dead in the West African Ebola outbreak nears 1,000, many people are calling for the wider production and release of untested medicines that might help patients.
As the world scrambles to stem the rapid spread of the killer Ebola virus, the World Health Organization hosted a meeting on Monday to discuss the ethics of using experimental drugs.
Spain has imported a U.S.-made experimental Ebola drug to treat a Spanish missionary priest evacuated from Liberia last week after testing positive for the killer virus.
The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health ...
(Medical Xpress)—Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.
Study identifies rational drug combinations that may overcome mantle cell lymphoma resistance to ibrutinib
Genomic analyses of tumor and healthy tissue from patients with mantle cell lymphomas that fail to respond to treatment with the anticancer drug ibrutinib (Imbruvica) or initially respond but then stop responding and progress, ...
Federal health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use against an unprecedented outbreak of the deadly virus in West Africa.
(HealthDay)—The antibacterial drug Orbactiv (oritavancin) has been approved by the U.S. Food and Drug Administration to treat drug-resistant skin infections in adults, the agency said in a news release.
(HealthDay)—Drug-related suicide attempts in the United States increased over a recent six-year period, with dramatic increases seen among young and middle-aged adults, health officials reported Thursday.
The world's top insulin maker, Novo Nordisk, reported rising quarterly profits on Thursday and said studies required to release long-acting insulin Tresiba in the US would be completed sooner than previously thought.
A fast-spreading Ebola epidemic sparked states of emergency in overwhelmed west African nations Thursday as the death toll neared 1,000 and an elderly Spanish missionary was evacuated for treatment at home.